|
PCBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.320300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.277800E-03 |
| Normal-vs-Stage2 |
2.531000E-01 |
| Normal-vs-Stage3 |
7.040100E-02 |
| Normal-vs-Stage4 |
3.875200E-01 |
| Stage1-vs-Stage2 |
5.807800E-01 |
| Stage1-vs-Stage3 |
6.005100E-04 |
| Stage1-vs-Stage4 |
7.884800E-01 |
| Stage2-vs-Stage3 |
2.785900E-02 |
| Stage2-vs-Stage4 |
8.839200E-01 |
| Stage3-vs-Stage4 |
7.879600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.863900E-02 |
| Normal-vs-AfricanAmerican |
8.634100E-02 |
| Normal-vs-Asian |
8.913800E-01 |
| Caucasian-vs-AfricanAmerican |
9.719200E-01 |
| Caucasian-vs-Asian |
6.177600E-01 |
| AfricanAmerican-vs-Asian |
6.261600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.139100E-03 |
| Normal-vs-Female |
8.017800E-01 |
| Male-vs-Female |
3.541800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.291200E-01 |
| Normal-vs-Extreme_Weight |
1.719390E-03 |
| Normal-vs-Obese |
8.033600E-01 |
| Normal-vs-Extreme_Obese |
6.908400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.329200E-01 |
| Normal_Weight-vs-Obese |
3.294600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.910000E-01 |
| Extreme_Weight-vs-Obese |
5.511900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.205400E-01 |
| Obese-vs-Extreme_Obese |
8.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.987600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.432440E-01 |
| Normal-vs-Age(61-80Yrs) |
5.935800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.743400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.069600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.480200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.985570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.219200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.773600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.755400E-04 |
| Normal-VS-Type2 PRCC |
8.214800E-01 |
| Normal-VS-KIRP CIMP |
5.850400E-01 |
| Normal-VS-Unclassified PRCC |
8.841600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.897700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.531700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.458200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.907400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.729600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.243600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.588990E-01 |
| Normal-vs-N1 |
1.884780E-01 |
| Normal-vs-N2 |
2.539800E-02 |
| N0-vs-N1 |
3.941500E-02 |
| N0-vs-N2 |
8.006400E-02 |
| N1-vs-N2 |
8.366800E-04 |
|
|
